Coronavirus disease 2019 (COVID-19): a perspective from China

ZY Zu, MD Jiang, PP Xu, W Chen, QQ Ni, GM Lu… - Radiology, 2020 - pubs.rsna.org
In December 2019, an outbreak of severe acute respiratory syndrome coronavirus 2
infection occurred in Wuhan, Hubei Province, China, and spread across China and beyond …

[HTML][HTML] A review of SARS-CoV-2 and the ongoing clinical trials

YF Tu, CS Chien, AA Yarmishyn, YY Lin… - International journal of …, 2020 - mdpi.com
The sudden outbreak of 2019 novel coronavirus (2019-nCoV, later named SARS-CoV-2) in
Wuhan, China, which rapidly grew into a global pandemic, marked the third introduction of a …

[HTML][HTML] C-reactive protein levels in the early stage of COVID-19

L Wang - Medecine et maladies infectieuses, 2020 - Elsevier
Background COVID-19 is a new infectious disease, for which there is currently no treatment.
It is therefore necessary to explore biomarkers to determine the extent of lung lesions and …

[HTML][HTML] Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2

F Salamanna, M Maglio, MP Landini, M Fini - Frontiers in medicine, 2020 - frontiersin.org
The explosion of the new coronavirus (SARS-CoV-2) pandemic has brought the role of the
angiotensin converting enzyme 2 (ACE2) back into the scientific limelight. Since SARS-CoV …

The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and …

RK Mohapatra, L Pintilie, V Kandi… - Chemical biology & …, 2020 - Wiley Online Library
COVID‐19 is highly contagious pathogenic viral infection initiated from Wuhan seafood
wholesale market of China on December 2019 and spread rapidly around the whole world …

[PDF][PDF] Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period

MA Ozma, P Maroufi, E Khodadadi, Ş Köse, I Esposito… - Infez Med, 2020 - researchgate.net
SUMMARY blood cells and factors and makes lung abnormalities in patients, which can be
detected by serological, molecular, and radiological techniques by detecting these changes …

[HTML][HTML] Main clinical features of COVID-19 and potential prognostic and therapeutic value of the microbiota in SARS-CoV-2 infections

Y He, J Wang, F Li, Y Shi - Frontiers in Microbiology, 2020 - frontiersin.org
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
(SARS) coronavirus 2 (SARS-CoV-2), has become a pandemic, infecting more than …

Coronavirus disease 2019: initial detection on chest CT in a retrospective multicenter study of 103 Chinese patients

Z Wen, Y Chi, L Zhang, H Liu, K Du, Z Li… - Radiology …, 2020 - pubs.rsna.org
Purpose To evaluate the performance of chest CT regarding the initial presentation of
patients suspected of having coronavirus disease 2019 (COVID-19). Materials and Methods …

Pregnancy outcomes, Newborn complications and Maternal-Fetal Transmission of SARS-CoV-2 in women with COVID-19: A systematic review

RK Gajbhiye, DN Modi, SD Mahale - MedRxiv, 2020 - medrxiv.org
Objective The aim of this systematic review was to examine published and preprint reports
for maternal and fetal outcomes in pregnant women with COVID-19 and also assess the …

CT quantification and machine-learning models for assessment of disease severity and prognosis of COVID-19 patients

W Cai, T Liu, X Xue, G Luo, X Wang, Y Shen, Q Fang… - Academic radiology, 2020 - Elsevier
Objective This study was to investigate the CT quantification of COVID-19 pneumonia and its
impacts on the assessment of disease severity and the prediction of clinical outcomes in the …